Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
about
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityConversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticeUpper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practiceThe promise of mHealth: daily activity monitoring and outcome assessments by wearable sensors.The relationship between spasticity in young children (18 months of age) with cerebral palsy and their gross motor function developmentKinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to strokeBudget impact analysis of botulinum toxin A therapy for upper limb spasticity in the United Kingdom.Botulinum toxin type-A in the management of spastic equinovarus deformity after stroke. Comparison of 2 injection techniques.Botulinum toxin in poststroke spasticityFeasibility of video clip analysis on effect of botulinum toxin-A injection for post-stroke upper limb spasticity.Reliability and validity of pendulum test measures of spasticity obtained with the Polhemus tracking system from patients with chronic strokeContributing factors analysis for the changes of the gross motor function in children with spastic cerebral palsy after physical therapyBotulinum toxin A (Dysport®): in dystonias and focal spasticity.Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.Systematic review of upper-limb function measurement methods in botulinum toxin intervention for focal spasticity.The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review.Therapeutic use of botulinum toxin in neurorehabilitation.Immediate Effect of a Single Session of Whole Body Vibration on Spasticity in Children With Cerebral Palsy.Physical impairment and walking function required for community ambulation in patients with cervical incomplete spinal cord injury.Mental techniques during manual stretching in spasticity--a pilot randomized controlled trial.Quantifying patterns of upper limb motor change following BTX-A injection in adult spasticity management.Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial.Clinical assessment of ankle plantarflexor spasticity in adult patients after stroke: inter-and intra-rater reliability of the Modified Tardieu Scale.Interventions for managing skeletal muscle spasticity following traumatic brain injury.Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity.Initial psychometric evaluation of the Arm Activity Measure (ArmA): a measure of activity in the hemiparetic arm.Measuring task performance after acquired brain injury: Construct and concurrent validity of 'Upper Limb Performance Analysis'.Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.Long-term effects of injection of botulinum toxin type A combined with home-based functional training for post-stroke patients with spastic upper limb hemiparesis.A single group, pretest-posttest clinical trial for the effects of dry needling on wrist flexors spasticity after stroke.Reduction in spasticity in stroke patient with paraffin therapy.Interrater reliability of the Modified Modified Ashworth Scale (MMAS) for patients with wrist flexor muscle spasticity.Upper limb spasticity management for patients who have received Botulinum Toxin A injection: Australian therapy practice.Arm Activity measure (ArmA) application for recording functional gain following focal spasticity treatment
P2860
Q24202197-AA21ACE3-E4FC-4BD5-A8A9-04643E0F1C36Q26766728-4D82AC7C-7C2E-4215-8E83-DB044CA45724Q30538210-10F55347-B6FC-4C30-B7F7-484FA689F4FAQ33438631-C38AAD53-81E4-41D8-A4A3-8E907AD411F0Q33499907-65474A2F-7359-4B62-9432-81B41D2AD33BQ35185960-CBCC9058-0947-4222-9443-3FC8B3703B6DQ35284574-EC782F41-E181-4B7C-9F89-0801ADB74E2DQ36504625-61C4997F-7BD8-4401-9CE4-B540A213A901Q36868342-D477C573-5056-46ED-A1FA-69C8A07BA2CBQ37005514-8174E76F-BB90-491E-B82F-3C7516E6B9DBQ37298972-821BCDE2-69D6-444E-887E-E18BB97D56ECQ37303472-B32EC69E-1CF1-435E-AB3F-C1E8E53862DCQ37888668-0B985A8A-CD16-4CCB-8CB8-2AF56140D71AQ37995787-A52EF8FB-0CC1-4B15-87EE-3159E331100CQ38102959-2C4604BD-98FA-41F2-918D-3A399F8E128FQ38263487-85EE9AC4-1DC3-4F2F-98B1-E5A42AFE1A8CQ38397501-9117FF79-BCC3-4F5C-9A7C-FF451F9DEF50Q38414925-EBC701EB-E32A-4A44-B14B-DFE83A41F164Q38684011-431837CE-DA87-4DF4-A1BA-FAA33A177A2AQ39234656-9E531737-770D-45D7-B838-3F6000F81B6CQ40008128-313BCB68-A981-40BB-AF3E-5F3F8D67F09EQ40609751-B3214F4E-28F1-4EAD-A702-A084112B3472Q41175112-24E660FD-6160-482F-AC8E-143FA598C410Q45298755-E29DC233-CB32-4F97-A100-D4443F43D9D9Q47428698-AC9BF0E2-A759-4EB7-BC5E-69BD0B51181DQ47616296-435B7FD5-5BBB-4B06-BB35-8139C4AAAA4FQ48155657-DD1F95F7-F1FC-41A7-A512-08DBB3DD6E35Q48166768-B1A11D42-C7F7-4FB6-969C-1A54AB28249DQ48785734-EBFC1737-B8BC-42DD-A1C6-D4F3511F5240Q49110787-D5BE2716-4C48-48B9-96E7-06EACD728B84Q50953981-9BA1FBB9-3F7D-4F71-9F96-314655B68D25Q50995701-89DC08BE-C487-48CB-AE34-5FEBF9BC6462Q51051219-5E64DA1D-4237-4640-8FC7-6ACCF7C2CD11Q51681496-C2EC037B-1D21-4B3D-A712-CA1A7DD9D003Q53620293-787DBA01-BE83-45B4-8B41-477E01E5DFDAQ57466784-0D708B41-11F8-4E3D-95AF-4AB4A54BD3E4
P2860
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@ast
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@en
type
label
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@ast
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@en
prefLabel
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@ast
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@en
P2093
P2860
P356
P1476
Does reducing spasticity translate into functional benefit? An exploratory meta-analysis.
@en
P2093
H P Francis
L Turner-Stokes
R S Kingswell
P2860
P304
P356
10.1136/JNNP.2003.025551
P407
P577
2004-11-01T00:00:00Z